Skip to main content
. 2017 Sep 30;8(49):86726–86735. doi: 10.18632/oncotarget.21418

Figure 6. Western blot analysis of p-RIPK3 and p-MLKL in Caco-2 cells treated with TNF-α (T) and Z-VAD-fmk (V) with or without necrosulfonamide (NSA).

Figure 6

*P<0.05 compared with the control group. p-RIPK3, phosphorylated receptor-interacting protein kinase 3; p-MLKL, phosphorylated mixed-lineage kinase domain-like.